Koyfin Home > Directory > Health Care > Retrophin Inc > Long-term Debt / Equity

Retrophin Inc Long-term Debt / Equity Chart (RTRX)

Retrophin Inc annual/quarterly Long-term Debt / Equity from 2014 to 2020.
  • Retrophin Inc Long-term Debt / Equity for the quarter ending June 06, 2020 was $68m a -25.53% decrease of -17m year over year
  • Retrophin Inc Long-term Debt / Equity for the last 12 months ending June 06, 2020 was $68m a -25.53% decrease of -17m year over year
  • Retrophin Inc Annual Long-term Debt / Equity for 2019 was $96m a 36.12% increase of 35m from 2018
  • Retrophin Inc Annual Long-term Debt / Equity for 2018 was $61m a 74.91% increase of 46m from 2017
  • Retrophin Inc Annual Long-term Debt / Equity for 2017 was $15m a 6.14% increase of 1m from 2016
Other Ratios Metrics:
  • Retrophin Inc Total Debt / Capital for the quarter ending September 09, 2018 was $40m a 66.90% increase of 27m year over year
  • Retrophin Inc Other Liabilities for the quarter ending December 12, 2018 was $91m a -9.17% decrease of -8m year over year
  • Retrophin Inc Total Debt / Equity for the quarter ending September 09, 2018 was $67m a 77.19% increase of 52m year over year
View Chart On Koyfin

Quarterly RTRX Long-term Debt / Equity Data

06/2020$68m
03/2020$92m
12/2019$96m
09/2019$85m
06/2019$75m
03/2019$72m
12/2018$61m
09/2018$60m
03/2018$15m
12/2017$15m

Annual RTRX Long-term Debt / Equity Data

2019$96m
2018$61m
2017$15m
2016$14m
2015$15m
2014$-116m